| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |